NCT02915523 2024-01-10Study of Avelumab With or Without Entinostat in Participants With Advanced Epithelial Ovarian CancerSyndax PharmaceuticalsPhase 1/2 Completed140 enrolled 25 charts
NCT03704467 2020-11-13Phase Ib/II Study of Carboplatin + M6620 + Avelumab in PARPi-resistant Ovarian CancerEMD SeronoPhase 1 Completed3 enrolled 11 charts
NCT03312114 2020-11-12Anti-PD-L1 and SAbR for Ovarian CancerUniversity of Texas Southwestern Medical CenterPhase 2 Terminated5 enrolled 4 charts